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CalciumWe have previously demonstrated that substitution of ATP with 2 deoxy-ATP (dATP) increased the magni-
tude and rate of force production at all levels of Ca2+-mediated activation in demembranated cardiac muscle.
In the current study we hypothesized that cellular [dATP] could be increased by viral-mediated overexpres-
sion of the ribonucleotide reductase (Rrm1 and Rrm2) complex, which would increase contractility of adult
rat cardiomyocytes. Cell length and ratiometric (Fura2) Ca2+ ﬂuorescence were monitored by video micros-
copy. At 0.5 Hz stimulation, the extent of shortening was increased ~40% and maximal rate of shortening was
increased ~80% in cardiomyocytes overexpressing Rrm1+Rrm2 as compared to non-transduced cardiomyo-
cytes. The maximal rate of relaxation was also increased ~150% with Rrm1+Rrm2 overexpression, resulting
in decreased time to 50% relaxation over non-transduced cardiomyocytes. These differences were even more
dramatic when compared to cardiomyocytes expressing GFP-only. Interestingly, Rrm1+Rrm2 overexpres-
sion had no effect on minimal or maximal intracellular [Ca2+], indicating increased contractility is primarily
due to increased myoﬁlament activity without altering Ca2+ release from the sarcoplasmic reticulum. Addi-
tionally, functional potentiation was maintained with Rrm1+Rrm2 overexpression as stimulation frequency
was increased (1 Hz and 2 Hz). HPLC analysis indicated cellular [dATP] was increased by approximately 10-
fold following transduction, becoming ~1.5% of the adenine nucleotide pool. Furthermore, 2% dATP was suf-
ﬁcient to signiﬁcantly increase crossbridge binding and contractile force during sub-maximal Ca2+ activation
in demembranated cardiac muscle. These experiments demonstrate the feasibility of directly targeting the
actin–myosin chemomechanical crossbridge cycle to enhance cardiac contractility and relaxation without af-
fecting minimal or maximal Ca2+. This article is part of a Special issue entitled "Possible Editorial".se 1; Rrm2, muscle ribonucleo-
reen ﬂuorescent protein; RT50,
o 50% and 90% Ca2+ decay.
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Systolic and/or diastolic cardiac function is compromised in a
number of cardiovascular diseases including myocardial infarc-
tion, ischemia/reperfusion injury, diabetes, high blood pressure
and hypertrophic and dilated cardiomyopathy. These pathophysi-
ological conditions often involve alterations in the Ca2+ cycle [1],
β-adrenergic responsiveness [2], and/or the contractile apparatus
of cardiomyocytes [3,4]. To date, therapeutic efforts have focused
primarily on approaches that increase [Ca2+]i that can be pro-arrhythmogenic and may impair ventricular ﬁlling by slowing di-
astolic relaxation [5]. Other approaches involving adrenergic
agents can have undesirable long-term consequences, including
signiﬁcant side-effects due to drug actions in non-target areas,
pro-arrythmogenic triggered activity, and potential for accelerat-
ed progression into heart failure [2]. Thus, new approaches to
combat cardiac dysfunction are desirable.
We have previously shown that replacing ATP with 2 deoxy-ATP
(dATP) as the substrate for contraction of demembranated cardiac
muscle increased isometric force and the rate of force development
and shortening at all levels of Ca2+ activation, including saturating
[Ca2+] (pCa 4.0) [6–9]. The presence of dATP results in enhanced my-
osin binding to actin and an increase in the rates of Pi and dADP re-
lease and myosin detachments. As such, contractile properties can
be improved by N50% over the range of [Ca2+]i seen in vivo. Thus, re-
placement of ATP with dATP offers the potential to improve contrac-
tion independent of changes in [Ca2+]i or adrenergic signaling.
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nated cardiac tissue and with isolated contractile proteins. As such,
its potential to improve intact cardiomyocyte contraction or cardiac
function in situ is unknown. Cellular production of dATP occurs in
the cytoplasm of mammalian cells by ribonucleotide reductase
(Rrm), which removes a hydroxyl moiety from the 2-position on
the ribose ring of ADP to produce dADP. dADP is then rapidly con-
verted to dATP. Rrm consists of two subunit proteins, a catalytic acti-
vator (Rrm1) and free radical containing (Rrm2) subunit and is
regulated by nucleoside triphosphate allosteric effectors [10]. While
the details of regulating cellular RR content, enzymatic activity and
cellular concentration [dATP] are unclear, it is known that both sub-
units are necessary for activity [11].
In the current study, we produced adenoviral vectors expressing cyto-
megalovirus (CMV) promoter driven Rrm1 or Rrm2, each along with
green ﬂuorescent protein (GFP) as a transduction reporter. Cultured
adult rat cardiomyocytes were transduced with these vectors, and the
rate and extent ofmyocyte contraction and relaxation and Ca2+ transient
rise and decay (Fura2 ﬂuorescence)weremonitored by videomicroscopy
following a 48 h viral incubation period. Here we show that these treat-
ments signiﬁcantly increased cellular [dATP], rate and extent of shorten-
ing, and rate of relaxation, with minimal effects on Ca2+ transients, at
0.5 Hz, 1 Hz and 2 Hz stimulation. Additionally, the [dATP] found in trans-
duced cells (1–2% of adenine nucleotide content) was sufﬁcient to in-
crease sub-maximal Ca2+ activated force in skinned cardiac trabeculae.
These experiments suggest that increases in cardiac intracellular Rrm
and/or the dATP pool can signiﬁcantly alter the actin–myosin crossbridge
cycle to enhance cardiac contractilitywithout impairing diastolic function
or cardiomyocyte Ca2+ handling.
2. Methods
Greater details of plasmid design and vector production, cell cul-
ture, contractile assessment, nucleotide binding afﬁnity, and western
blot analysis are provided in online supporting information.
2.1. Animal and tissue handling
These studies were approved by the University ofWashington (UW)
Animal Care Committee and conducted in accordance with federal
guidelines. Animals were cared for in accordance with US NIH Policy
on Humane Care and Use of Laboratory Animals in the Department of
Comparative Medicine at UW. Adult rat (Fischer 344) cardiomyocytes
(ARCs)were isolated fromheart using aortic retrograde perfusion for en-
zymatic (collagenase/protease) dispersion of cells [12]. Neonatal Rat
Cardiomyocytes (NRCs) were isolated by enzymatic dispersion from
1 to 3-day old newborn Fischer 344 rats as previously described
[13]. Rat cardiac trabeculae were dissected from the right ventricle of
male Sprague–Dawley rats, chemically demembranated, and pre-
pared for mechanical measurements as previously described
[13]. Trabeculae averaged 1.3±0.2 mm in length by 170±30 μm
in width.
2.2. Plasmid design and virus production
HEK293 cells were used to generate adenoviral vectors [14]
expressing Rrm1 or Rrm2 from the CMV promotor. Both vectors con-
tained a second expression cassette for green ﬂuorescent protein
(GFP) as a transduction reporter protein, and we also expressed a
vector for GFP-only. Virus was introduced to cardiomyocytes at
~250 particles per cell.
2.3. Nucleotide binding afﬁnity
Rapid kinetic measurements of nucleotide binding and actin–
myosin dissociation were taken at 10 °C and 20 °C (Hi-Tech ScientiﬁcSF-61 DX2 stopped-ﬂow system) as previously described [15] using
pyrene labeled actin and myosin S1. Myosin was puriﬁed from
mouse hearts, rabbit soleus, and rabbit bulk fast muscle as previously
described [16,17]. Actin was puriﬁed from rabbit skeletal muscle [18].
The stopped-ﬂow transients were ﬁtted to one or two exponentials
by non-linear least squares curve ﬁtting using the Kinetic Studio soft-
ware (TgK Scientiﬁc). All experiments were carried out in 20 mM
Cacodylate buffer, pH 7.0 containing 100 mM KCl, and 5 mM MgCl2.
The rate constant for ATP-induced actin-S1 dissociation (kobs) was
determined from Eq. (1) based on SI Scheme 1:
kobs ¼ kþ2K1
ATP½ 
1þ K1 ATP½ 
ð1Þ
2.4. Contractile assessments
In modiﬁed Tyrodes buffer at ambient temperature (22–24 °C) and
at 37 °C, cell shortening and relaxation of arbitrarily selected stimulated
cardiomyocyteswas recorded using IonOptix system videomicroscopy.
(IonOptix, Milton, MA, USA). Calcium transients induced by electrical
stimulation were measured in Fura2 loaded cells using IonOptix equip-
ment as described [19]. Fura2 ﬂuorescence was measured using an
IonOptix spectrophotometer (Stepper Switch) attached to a ﬂuores-
cence microscope. Emitted Fura2 ﬂuorescence was collected by the
40X objective, passed through a 510 nm ﬁlter and detected by a photo-
multiplier tube. For demembranated trabeculae, steady-state force and
high frequency sinusoidal stiffness (to determine crossbridge binding)
were measured in a custom built mechanical apparatus at 15°
and 22 °C during sub-maximal (pCa 5.6) and maximal (pCa 4.0)
Ca2+ activation as previously described [20]. Experimental physi-
ological Ca2+ solutions were calculated as previously described
for trabeculae mechanics [21].
2.5. Data processing and statistical analysis
Maximal cardiomyocyte shortening and relengthening and calcium
transient rise and decaywere calculated ofﬂine using IonOptix software
to determine the maximum of the ﬁrst derivative of these transients.
Times to peak shortening and 50% and 90% return to baseline were
also calculated ofﬂine. Statistical differences were determined by
ANOVA, with Student-Newman–Keuls as a post-hoc pairwise test (Sig-
maPlot 11). Trabeculaewere compared using paired t-tests. Differences
at p-valueb0.05 were considered statistically signiﬁcant. Data is dis-
played as mean±s.e.m.
3. Results
Transduction with recombinant adenovirus containing appropriate
cDNA constructs driven by the CMVpromoterwas used to induce overex-
pression of muscle ribonucleotide reductase 1 (Rrm1) and 2 (Rrm2) in
cultured adult and neonatal rat cardiomyocytes. Each adenovirus also
contained a second expression cassette for green ﬂuorescent protein
(GFP), which was used as a reporter protein identifying successful trans-
duction. Cardiomyocyteswere infectedwith adenovirus containing genes
for [Rrm1+GFP and Rrm2+GFP] or [GFP] for 2 days. Successful gene
transfer, grossly indicated by green ﬂuorescence with microscopy, indi-
cated nearly 100% transduction efﬁciency (Supplemental Fig. 1). This is
consistent with previous studies using cardiomyocytes [22]. Cell survival
over this periodwas similar for all groups, including non-transduced con-
trol cells, suggesting that these viral vectors did not compromise cardio-
myocyte viability. Cardiomyocyte numbers and sarcomere lengths are
summarized in Table 1. There was no difference in resting sarcomere
length between groups, indicating that overexpression of Rrm1+Rrm2
(or GFP) did not increase calcium independent activation.
Table 1
Cell dimensions of experimental groups.
N n SL (μm) Cell length (μm)
Non-transduced 5 51 1.88±0.03 90.4±1.8
Control (GFP) 5 50 1.84±0.03 89.1±1.5
R1R2 (GFP) 5 52 1.82±0.02 91.6±1.7
N = number of hearts, n = number of cardiomyocytes.
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The effects of Rrm1+Rrm2 overexpression on extent and rate of
stimulated shortening-relengthening of adult rat cardiomyocytes
were determined using video length-detection (IonOptix). Fig. 1a
shows representative shortening traces, and Fig. 1b shows represen-
tative Ca2+ transients (Fura2 ﬂuorescence), for non-transduced
(black), GFP-only (green), and Rrm1+Rrm2 (red) transduced cardi-
omyocytes. The data for all measurements at 0.5 Hz is summarized in
Table 2. Cardiomyocytes transduced with Rrm1+Rrm2 (+GFP) had
a signiﬁcantly greater magnitude and rate of shortening vs. non-
transduced cardiomyocytes and GFP-only transduced controls. This
is illustrated in Fig. 1c, which shows % differences in rate and extent
of shortening, relaxation rate, and time to 50% and 90% relaxation.
While GFP has been reported to have a deleterious [23] or no effect
[19,24] on contractility, it did not appear to act as a contractile inhib-
itor in this study. However, GFP did slow the 90% relaxation time,
which was accompanied by a slower time to 50% and 90% decay
of the Ca2+ transient (Fig. 1c, Table 2). Regardless, Rrm1±Rrm2
overexpression increased the rate of relaxation and decreased the
time to 50% relaxation, and this effect may be somewhatFig. 1. Representative traces and data summary. Representative cell length traces (a) and Ca
Rrm1+Rrm2+GFP (red) transduced cardiomyocytes. Percentage change in contractile (c
myocytes, stimulated at 0.5 Hz, as compared to non-transduced myocytes. Vshort = velo
RT50,90 = time to 50% and 90% relaxation, respectively; FL = ﬂuorescence; DT50,90 = timeunderestimated due to the presence of GFP. Fig. 1d illustrates the % dif-
ference in Ca2+ transient properties, including minimal and maximal
Ca2+, and the time to 50% and 90% Ca2+ decay. Therewas no signiﬁcant
effect from either GFP or Rrm1+Rrm2+GFP on minimal and maximal
Ca2+, indicating that enhanced contractilitywith Rrm1+Rrm2was pri-
marily due to increasedmyoﬁlament responsiveness to activating Ca2+.
Interestingly, Rrm1±Rrm2 overexpression did speed Ca2+ re-seques-
tration, as indicated by a reduction in the time to 50% and 90% decay.
This could be due to increased SERCA activity and, in part, explain the
increased maximal rate of cardiomyocyte relaxation at 0.5 Hz
(Table 2) stimulation. Faster relaxation in Rrm1+Rrm2 overexpressing
cardiomyocytes could also be due to faster crossbridge cycling, that
leads to shortening induced thin ﬁlament inactivation and Ca2+ release
from troponin C.
It is important to determine whether Rrm1+Rrm2 overexpression
affects normal cellular response to increased stimulation frequency, as
changes in heart rate are a normal physiological adaptation to systemic
demand. Fig. 2 summarizes the effect of increased stimulation frequen-
cy (0.5 to 1 to 2 Hz) on fractional shortening (2a), shortening velocity
(2b), relaxation velocity (2c), and time to 90% relaxation (2c). The con-
tractile response to stimulation frequency was similar between groups,
and Rrm1+Rrm2 transduced cardiomyocytes maintained functional
potentiation at all frequencies. Importantly, increased pacing frequency
is associatedwith a positive lusitropic effect, shortening the time to 90%
relaxation in all groups. There was little difference in non-transduced
myocytes vs. GFP-only transducedmyocytes, except that time to 90% re-
laxation is longer at 0.5 Hz in GFP-only myocytes. The effect of stimula-
tion frequency on Ca2+ transientswas also assessed, and is summarized
in Fig. 3 forminimal Ca2+ (3a), maximal Ca2+ (3b) and time to 50% (3c)
and 90% (3d) Ca2+ decay (DT50, DT90). As with contraction, there was
no difference in Ca2+ transient behavior with increased stimulation2+ transients (b, Fura-2 ﬂuorescence) of non-transduced (black), GFP-only (green), and
) and Ca2+ transient (d) properties of GFP-only and Rrm1+Rrm2+GFP transduced
city of shortening; FS = fractional shortening; Vrel = maximal relaxation velocity;
to 50% and 90% Ca2+ decay, respectively *pb0.05 as compared to Non-Transduced.
Table 2
Contractile and Ca2+ transient values at 0.5 Hz stimulation.
Fractional
shortening (%)
Maximal
shortening
rate (μm/s)
Time to
peak
(ms)
Maximal
relaxation
rate (μm/s)
RT50 (ms) RT90 (ms) Minimal Ca2+
(fura ratio units)
Maximal Ca2+
(fura ratio units)
DT50 (ms) DT90 (ms)
Non-transduced 6.2±0.4 61.1±4.4 173±12 46.8±6.5 208±28 330±59 1.10±0.02 1.22±0.04 246±26 666±74
Control (GFP) 5.5±0.5 56.5±4.4 217±15⁎ 37.5±4.3 202±25 518±42⁎ 1.12±0.03 1.25±0.04 297±24 893±63⁎
R1R2 (GFP) 8.9±0.5⁎ 109.5±8.7⁎ 177±7 117.9±13.1⁎ 113±7⁎,† 265±23† 1.14±0.02⁎ 1.23±0.03 153±10⁎,† 435±34⁎,†
⁎ pb0.05 as compared to No Treat for all groups.
† pb0.05 as compared to GFP for all groups.
897F.S. Korte et al. / Journal of Molecular and Cellular Cardiology 51 (2011) 894–901frequency between non-transduced and Rrm1+Rrm2 transduced
myocytes. GFP-only transduced cardiomyocytes had a slight increase
in minimal Ca2+ at 2 Hz, and an increase in maximal Ca2+ at 1 Hz and
2 Hz, as compared to non-transduced myocytes, but the times to 50%
and 90% decay were similar. As at 0.5 Hz, the times to 50% and 90%
decay were decreased (faster decay) in Rrm1+Rrm2 transduced myo-
cytes at both 1 and 2 Hz. Most importantly, although higher stimulating
frequencies increased relaxation parameters in all groups, the relative
increase in relaxation kinetics was maintained with Rrm1+
Rrm2 overexpression, such that relaxation was improved, not im-
paired. Results for 1 Hz and 2 Hz stimulation are summarized in
Supplemental Tables 1 and 2, respectively.
We chose to perform these experiments at room temperature
(22–24 °C) to compare with the predominant number of reports for
cultured cardiomyocytes in the literature [25–29]. However, a subset
of measurements was made at 37 °C to determine if the effects persist
at physiological temperature. At 37 °C (Supplemental Table 3), short-
ening and Ca2+ transients were faster than at 22–24 °C, but were sim-
ilarly increased in cardiomyocytes transduced with Rrm1+Rrm2 vs.
GFP-only transduced and non-transduced cells. Similarly, the rates
of Ca2+ release and re-uptake were also increased at 37 °C vs. roomFig. 2. Effect of stimulation frequency on contractile properties. Rrm1+Rrm2 transduced m
duce open circles) and non-transduced myocytes (closed circles) but show elevated fracti
(c) and time to 90% relaxation (d) are also similar between groups, with time to relaxati
Transduced, † = pb0.05 as compared to GFP, ‡ = pb0.05 as compared to 0.5 Hz for all gtemperature, but with Rrm1+Rrm2 overexpression resulting in fas-
ter Ca2+ transient decay as was observed at ambient temperature.
Since there was little difference between groups in minimal
and maximal Ca2+, changes in contractility can best be explained by
a change in myoﬁlament responsiveness to activating Ca2+. This is
illustrated in Fig. 4 as contractile response, deﬁned here as cardio-
myocyte fractional shortening divided by maximal fura2 ﬂuorescence
(peak Ca2+). Cardiomyocytes expressing Rrm1+Rrm2 had signiﬁ-
cantly higher contractile response than non-transduced or GFP trans-
duced cardiomyocytes at all stimulation frequencies. There was no
difference in contractile response between GFP only or non-
transduced myocytes except at 2 Hz, which can be primarily be
attributed to increased maximal Ca2+ in GFP only myocytes with no
increase in fractional shortening, reducing response.
3.2. Protein and nucleotide analysis
To verify increased RrmmRNA, Rrm protein, and dATP production in
Rrm1+Rrm2 transduced cells, neonatal rat cardiomyocytes were col-
lected and processed for RT-PCR, western blotting and HPLC analysis of
intracellular [ATP] and [dATP]. Neonatal cardiomyocytes were used toyocytes (open triangles) respond similarly to stimulation frequency as GFP-only trans-
onal shortening (a) and shortening velocity (b) at all frequencies. Relaxation velocity
on shortening as stimulation frequency increases. * = pb0.05 as compared to Non-
roups.
Fig. 3. Effect of stimulation frequency on Ca2+ handling properties. Rrm1+Rrm2 transduced myocytes (open triangles) respond similarly to stimulation frequency as non-transduced
myocytes (closed circles) in minimal (a) and maximal (b) ﬂuorescence, while GFP-only transduced myocytes (closed circles) showed a greater increase in both as frequency increased.
Aswith cardiomyocyte relaxation, Ca2+ transient decay time (DT) to 50% (c) and 90% (d) is shortenedwith increased stimulation frequency, but both are dramatically shortened in R1R2
transduced cardiomyocytes. * = pb0.05 as compared to Non-Transduced, †= pb0.05 as compared to GFP, ‡= pb0.05 as compared to 0.5 Hz for all groups.
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as intracellular [dATP] is known to be in the pM range. Although there are
structural differences between neonatal and adult cardiomyocytes, it is
important to note that Rrm1+Rrm2 over-expression increased contrac-
tility to a similar extent in both cell types (Supplemental Fig. 2). Interest-
ingly, as neonatal cardiomyocytes have been used to study the effects of
cellular engraftment followingmyocardial infarction [13], improved con-
tractility in these cells may be another mechanism to improve cardiac
function following an infarct. Rrm1 and Rrm2mRNAwas signiﬁcantly in-
creased following adenoviral tranduction (Supplemental Fig. 3). Concom-
itant with this, Figs. 5a and b illustrate that Rrm1 and Rrm2 transduced
cardiomyocytes had greater than 24-fold and 46-fold increased Rrm1Fig. 4. Contractile responsiveness. Contractile response as assessed as fractional short-
ening divided by maximal fura ﬂuorescence (peak Ca2+) indicates that Rrm1+Rrm2
transduced cardiomyocytes (open triangles) are signiﬁcantly more responsive to Ca2+
at all stimulation frequencies, while GFP-only transduced cardiomyocytes (open circles)
are less responsive to Ca2+ only at 2 Hz stimulation frequency as compared to non-
transduced cardiomyocytes (closed circles). * = pb0.05 as compared to Non-transduced,
†= pb0.05 as compared to GFP.and Rrm2 protein content, respectively. GAPDH was used as a loading
control. Fig. 5c illustrates that Rrm1+Rrm2 transduced cardiomyocytes
had ~10-fold increased cellular [dATP] as compared to GFP transduced
cardiomyocytes (an increase to 0.35 nmol/mg protein). While this is ro-
bust, since [dATP] normally comprises less than 0.2% of total adenine tri-
phosphate nucleotide, this increase in [dATP] represents only ~1.5% of the
total adenine nucleotide pool. This suggests that only a small amount of
dATP is required to signiﬁcantly increase cardiomyocyte contractility.
To determine how the relatively small increase in cellular [dATP]
might inﬂuence crossbridge binding and contraction, we compared the
rates of nucleotide binding+acto-myosin S1 dissociation (kobs) for
ATP vs. dATP. Fig. 6 shows the effect of increasing [ATP] and [dATP] on
kobs at 10 °C and 20 °C for mouse cardiac (alpha) myosin. There was no
difference in kobs between ATP and dATP at any [NTP] at either temper-
ature. This was also true for fast and slow skeletal S1 myosin (Supple-
mental Fig. 4). This data indicates that NTP binding to S1, and
subsequent S1 dissociation from actin, is not different for dATP vs. ATP.
Thus, it appears that enhanced contractility of R1R2 overexpressing car-
diomyocytes is not likely due to a greater myosin afﬁnity for dATP.
3.3. Crossbridge binding and force in demembranated trabeculae
To determine if small amounts of dATP increase force production,
we activated contraction of demembranated rat cardiac trabeculae at
pCa 5.6 (sub-maximal) and pCa 4.0 (maximal) in solutions containing
5 mM NTP, composed of either 100% ATP or 2% dATP, 98% ATP. The
sub-maximal Ca2+ activation approximates the force levels attained
during twitch activity, and was 30±7% of maximal force (88.4±
1.9 mN/mm2). The example force trace in Fig. 7a demonstrates that
moving a trabeculae from 100% ATP solution to the 2% dATP, 98% ATP
solution resulted in a signiﬁcant increase in force, which was reversible
upon tansfer back to the 100% ATP solution. Fig. 7b summarizes this in-
crease for all trabeculae activated and shows that 2% dATP, 98% ATP in-
creased force 17.1±0.02% (pb0.05) at pCa 5.6 but not during maximal
Fig. 5. Increased Rrm and dATP. (a) Western blot of Rrm1 transduced neonatal rat cardiomyocytes probed with anti-Rrm1 antibody indicates a N24-fold increase in Rrm1. (b) Western
blot of Rrm2 transduced neonatal rat cardiomyocytes probed with anti-Rrm2 antibody indicates a N46-fold increase in Rrm2. (c) Rrm1+Rrm2 overexpression signiﬁcantly increased
intracellular [dATP] by N10-fold in neonatal rat cardiomyocytes as assessed by HPLC analysis. * = pb0.05 as compared to GFP transduced cardiomyocytes.
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high frequency sinusoidal stiffness measurements, increased 16.0±
0.03% (pb0.05), which indicates that the increased force with 2%
dATP, 98% ATP is due to increased crossbridge binding. Thus the data
demonstrate that a relatively small increase in cellular [dATP] (1–2%
of adenine nucleotide) is sufﬁcient to signiﬁcantly increase the contrac-
tile strength of intact cardiomyocytes by increasing the number of
strong crossbridges.
4. Discussion
The main objective of this study was to determine if overexpression
of ribonucleotide reductase (Rrm1+Rrm2) increases cellular [dATP]
and, in turn, increases contractility in intact cardiomyocytes withoutFig. 6. Nucleotide binding and actin–myosin dissociation. Rapid kinetic measurements
of nucleotide binding and actin–myosin dissociation of mouse cardiac myosin taken at
10 °C (top) and 20 °C (bottom). There was no difference in kobs between ATP and dATP
at any [NTP] at either temperature.adversely affecting cardiomyocyte relaxation. Overexpression of Rrm1
+Rrm2 resulted in increased cellular [dATP] to ~1.5% of the total adenine
nucleotide pool, and this dramatically increased the extent and rate
of myocyte shortening and rate of myocyte relaxation, while having no
apparent effect Ca2+ transient properties.
Previous experiments in our laboratory using skinned cardiac trabec-
ulae showed dATP increased isometric force and the rate of force devel-
opment and shortening at all levels of Ca2+ activation, including
saturating [Ca2+] (pCa 4.0), but these studies were performed with
100% replacement of 5 mM ATP with 5 mM dATP in bathing solutions
[6–8]. For our current study in intact cardiomyocytes we did not expect
overexpression of Rrm1+Rrm2 to result in high (mM) levels of dATP.
Others have shown that as little as 10% replacement of ATP with dATPFig. 7. Isometric force increases with 2% dATP. Isometric force development of demem-
branated cardiac trabeculae activated with 2% dATP, 98% ATP vs. 100% ATP (5 mM
[NTP] total). (a) Force trace with pCa 5.6 activation. (b) Summary of % increase in
force with 2% dATP in activation solutions for sub-maximal (pCa 5.6), but not maximal
(pCa 4.0) Ca2+ activation.
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(15 °C) [30] and replacement of ~30% increased contractility in intact
embryonic chick cardiomyocytes [31]. In our studies the observed large
increases in contractility of adult rat cardiomyocytes occurredwith a rel-
atively small increase in cellular [dATP] resulting from overexpression of
Rrm1+Rrm2, and a similar amount (2% dATP) signiﬁcantly increased
sub-maximal force in dememembranated trabeculae. It is possible
there was a small population of contaminating cells (e.g., ﬁbroblasts)
that were either not as easily transduced or overexpressed less Rrm1+
Rrm2, which would lead to underestimation of cardiomyocyte [dATP]
from the HPLC analysis. However, considering the relative scarcity of
non-cardiomyocyte cells in our culture, this confounding effect should
be minimal. Our force measurements with demembranated trabeculae
suggest this relatively small concentration of cellular [dATP] is sufﬁcient
to result in the increased contractility seen in intact cardiomyocytes. This
may be advantagous in that large increases in [dATP] are not required to
achieve contractile potentiation, thus reducing the potential for negative
side effects [31,32].
It is interesting to speculate on how a relatively small increase in
cellular dATP can improve cardiomyocyte function. Contractile re-
sponse estimations (Fig. 4) indicate that the increased contractility
in Rrm1+Rrm2 transduced myocytes is primarily myoﬁlament
based, thus dATP likely has its effect primarily by improving myosin
binding (to actin) and crossbridge cycling. The increase in sub-
maximal steady-state force and stiffness seen in demembranated
trabeculae activated with 2% dATP, 98% ATP supports this idea. This
is similar to experiments where faster (alpha) myosin has been
expressed in cardiomyocytes that normally express slower (beta)
myosin, resulting in functional potentiation with no effect on Ca2+
transient amplitude [24]. One possibility we examined was that
dATP afﬁnity for cardiac myosin is much greater than ATP afﬁnity
for myosin, such that the increased level in cells (with Rrm1+Rrm2
overexpression) was utilized almost speciﬁcally by myosin. We
have previously shown that ATP and dATP have similar binding afﬁn-
ity to skeletal myosin and actomyosin and a similar γ-phosphate
cleavage equilibrium by myosin [33]. Here we report that NTP bind-
ing and subsequent dissociation of cardiac α-myosin from actin do
not differ for dATP vs. ATP, as assessed by kobs (Fig. 6). This suggests
that dATP has a similar binding afﬁnity for cardiac myosin as ATP
(Supplemental Scheme 1). For skeletal myosin we have also shown
post-hydrolysis crossbridge binding and the rate of crossbridge de-
tachment is increased with dATP [33]. This can explain an increase
in the Ca2+ sensitivity of tension development, and a faster rate of
tension development and shortening velocity in skinned skeletal
muscle [33–35]. While we have not performed a detailed chemo-me-
chanical analysis with dATP in cardiac muscle, we have shown that it
increases maximal crossbridge binding (as indicated from stiffness
measurements) and isometric force by ≥40%, in addition to increas-
ing ktr and unloaded shortening velocity [6]. We have also shown
that dATP signiﬁcantly increases isometric force and ktr in cardiac
muscle at all levels of Ca2+, whether the demembranated cardiac
muscle was expressing primarily α- or β-myosin heavy chain [8].
This is important because, unlike skeletal muscle, the intracellular
[Ca2+] during a cardiac muscle twitch only reaches a level that is ap-
proximately within the half-maximally activating range. Additionally,
cooperative thin ﬁlament activation in cardiac muscle is strongly
inﬂuenced by strong binding crossbridges [7]. Based on our results
that 2% dATP, 98% ATP signiﬁcantly enhanced crossbridge binding
and force in demembranated trabeculae, we propose that dATP re-
sults in the formation of a few additional strong binding crossbridges
early on during the twitch, which provides a positive feedback ampli-
ﬁcation of thin ﬁlament activation. This results in greater total cross-
bridge binding, including crossbridges using ATP, during the
cardiomyocyte twitch. Therefore, for our current experiments with
cultured cardiomyocytes, it may be that a small increase in initial
binding of myosin S1 heads was enough to cooperatively increasethin ﬁlament activation, resulting in the increased magnitude and
rate of shortening. Future studies will be required to determine how
R1R2 overexpression and resulting increases in cellular [dATP] affect
cardiac function in situ, but previous experiments have demonstrated
that even demembranated cardiomyocyte function translates to car-
diac organ function [36]. Interestingly, a recent study investigating a
small molecule myosin activator (omecamtiv mecarbil) demonstrat-
ed functional potentiation at the cardiomyocyte level, via increased
crossbridge binding, that was very similar to results in the present
study [37]. However, this molecule appeared to slow the times to
peak shortening and 50% and 90% relaxation, which would likely in-
crease time spent in systole while decreasing time spent in diastole.
In contrast, Rrm1+Rrm2 over-expression increased fractional short-
ening without increasing the time to peak shortening, and shortened
the times to 50% and 90% relaxation (Fig. 1a, Table 1, Supplemental
Tables 1–4), which would allow more time for ventricular ﬁlling.
There was no adverse effect on relaxation with overexpression of
Rrm1+Rrm2 (and the subsequent increase in [dATP]), in fact myocyte
relaxation was enhanced. It is possible that this resulted, at least in
part, from a faster decay of the Ca2+ transient. dATP could be used by
other ATPases (besides myosin) such as the sarcoplasmic Ca2+ ATPase
(SERCA), the plasma membrane Ca2+ ATPase (PMCA), and may also in-
directly effect activity of the sodium/calcium exchanger (NCX) [38]. An
increase in SERCA activity could explain the increased decay rate of the
Ca2+ transient, especially at 0.5 and 1.0 Hz stimulation. However, in-
creased SERCA activity is known to increase SR Ca2+ stores [39], making
more Ca2+ available for release during activation, which was not ob-
served in Rrm1+Rrm2 transduced cardiomyocytes (Fig. 1d). Further-
more, increased PMCA and NCX activity should result in a Ca2+
transient decay over time by extruding Ca2+ out of the cell. Because
~95% of activating Ca2+ is released from the SR in rat cardiomyocytes
[40,41], Ca2+ extrusion from the cell would lead to progressively de-
creased Ca2+ transient amplitudes and contraction, which was not ob-
served over the duration of these experiments. However, the speciﬁc
mechanism behind increased Ca2+ transient decay rate warrants future
investigation.
Since dATP increases the rate of crossbridge detachment [6,34] this
may also explain a faster rate of relaxation in the current experiments
with cultured cardiomyocytes. Although speciﬁc mechanisms that gov-
ern relaxation in intact cardiac muscle are not known, early phase relax-
ation in cardiac and skeletal myoﬁbrils has been shown to be governed
by the rate of crossbridge dissociation [42–45]. Thiswould also be consis-
tent with our ﬁnding that cardiomyocyte contractility was increased
with Rrm1+Rrm2, because shortening rate in unloaded cells (as in cul-
ture) is primarily determined by crossbridge detachment rates [46,47],
although cultured cardiomyocytes still contract against a small internal
load. It is also possible that increased crossbridge detachment rate with
dATP accelerates cooperative thin ﬁlament inactivation, by more rapidly
decreasing the bound crossbridge population as thin ﬁlament Ca2+ bind-
ing decreases during relaxation. A more rapid decrease in bound cross-
bridge population could also increase the rate of Ca2+ dissociation from
troponin, as demonstrated by Tikunova et al. (2010) [48], further acceler-
ating relaxation.
In summary, dATP provides a dual beneﬁt of positive inotropy and
lusitropy in cultured rat cardiomyocytes, with little alteration of Ca2+
transient properties, and also increases isometric force production at
physiologically relevant [Ca2+]. These results warrant progression to an-
imal studies to determine its potential to improve global cardiac function
in normal and diseased hearts.Disclosures
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